Endocrine Dysfunction and Quality of Life After Subarachnoid Hemorrhage

Completed

• Conditions: Endocrine Dysfunction; Cerebral Infarctions; Quality of Life

• Registration Number: NCT01101711
• Lead Sponsor: Lund University Hospital

Brief Summary

Investigation of the incidence of endocrine dysfunction following subarachnoid hemorrhage (SAH), and to see if this has a relation to CNS lesions as evaluated by MRI and to common symptoms after SAH such as general exhaustion, lack of initiative, increased sleep demand and reduced quality of life.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-11
• Study First Submitted: 2010-04-08
• Study First Submitted QC: 2010-04-08
• Study First Posted: 2010-04-12
• Primary Completion: 2011-02
• Status Verified: 2012-09
• Study Completion: 2012-09
• Last Update Submitted: 2012-09-06
• Last Update Posted: 2012-09-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• acute aneurysmal subarachnoid hemorrhage

Exclusion Criteria

• unable to give informed consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Department of Neurosurgery; 🇸🇪 Lund, Sweden